On February 5, 2018 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reported plans to report fourth quarter and full year 2017 financial results on February 21, 2018 (Press release, Ligand, FEB 5, 2018, View Source [SID1234523736]). Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Fourth Quarter and Full Year 2017 Earnings Call

What: Ligand conference call to discuss financial results and provide general business updates

When: Wednesday, February 21, 2018

Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)

Conference Call: (833) 591-4752 within the U.S.
(720) 405-1612 outside the U.S.
Conference ID – 2391528

Webcast:

Live conference call webcast and replay accessible at www.ligand.com